Your shopping cart is currently empty

c-Met-IN-17 is a potent inhibitor of c-Met kinase with an IC50 of 0.031 μM, making it relevant for anticancer research. [1]
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | c-Met-IN-17 is a potent inhibitor of c-Met kinase with an IC50 of 0.031 μM, making it relevant for anticancer research. [1] |
| In vitro | c-Met-IN-17 (compound 29) exhibited an IC50 value of 0.068 μM for inhibiting D1228V c-MET enzymatic activity, as assessed by the ADP-Glo assay [1]. |
| In vivo | c-Met-IN-17, administered intravenously at a dose of 0.5 mg/kg to Wistar rats, demonstrated excellent bioavailability over a 24-hour period [1]. Pharmacokinetic analysis in Wistar rats [1] revealed the following parameters: clearance (Cl) at 60 mL/min/kg, steady-state volume of distribution (Vss_obs) at 4.6 L/kg, and a bioavailability of 100%. |
| Molecular Weight | 374.37 |
| Formula | C21H15FN4O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.